Analysts Set DexCom, Inc. (NASDAQ:DXCM) Target Price at $131

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fifteen brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the […]

Related Keywords

United States , Stevenr Altman , Leerink Partnrs , Stifel Nicolaus , Valley National Advisers Inc , Fortis Capital Advisors , Fulton Bank , Jpmorgan Chase Co , Centaurus Financial Inc , Securities Exchange Commission , Dexcom Inc , Nasdaq , Citigroup , Lincoln National Corp , Get Free Report , Director Steven , Exchange Commission , Capital Advisors , National Advisers , National Corp , Get Free , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Ratings , Consensus ,